Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |